ArticleFrontiers in health services2025

Demonstrating the value for money of implementing evidence-based treatment: the case for further investment in magnesium sulphate as a neuroprotectant for preterm births.

Carlos Sillero-Rejon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.